Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / KRTX - Karuna Therapeutics: Fundraising Makes For Buying Opportunity


KRTX - Karuna Therapeutics: Fundraising Makes For Buying Opportunity

Investment Thesis

With the benefit of hindsight, the optimal time to have bought Karuna would have been any time between its IPO in June this year and before the results of its recent phase II clinical trials were announced. The company met its primary endpoint in trials of its flagship drug KarXT for treatment of acute psychosis in patients with schizophrenia, causing Karuna's share price to rocket from around $18.50 to just above $137; a 641% increase.

The company has decided to make hay while the sun shines and announce a stock offering at $96

Read more ...

Stock Information

Company Name: Karuna Therapeutics Inc.
Stock Symbol: KRTX
Market: NASDAQ
Website: karunatx.com

Menu

KRTX KRTX Quote KRTX Short KRTX News KRTX Articles KRTX Message Board
Get KRTX Alerts

News, Short Squeeze, Breakout and More Instantly...